Pol Quintana Mireia ventura

Slides:



Advertisements
Similar presentations
Strategic, service provider and user responses to reducing fatal and non-fatal poisonings Rowan Williams, Development Manager, Drugaid.
Advertisements

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
HIV Clinical Trials Janice Price, M.Ed, RN HIV Clinical Research Program Coordinator Swedish Medical Center Seattle, WA USA.
DR. SHABANA ALI. Adverse Drug Reactions (ADR) Harm associated with the use of a given medications OR Unwanted or harmful reaction experienced after the.
ANTHRAX CASSIDI, CARLEY, AND DOUGLAS. WHAT IS ANTHRAX…? Anthrax is an infectious disease caused by bacteria called Bacillus anthracis. Infection in humans.
Introduction Health Economics. A course in applied microeconomics, which uses microeconomics to understand the healthcare system or the market for healthcare.
BATH SALTS By: Erin Winott. What are they  A drug called MDPV, mormethylenedioxypyrovalerone  Also known as “Ivory Wave,” “Purple Wave,” Vanilla Sky,”
1.6 focuses on the following drug related issues: 1.Personal, interpersonal and societal influences on an individuals drug use. 2.The effect of drugs on.
NACD and NDST 8 th March 2007 A Joint Report by the National Drugs Strategy Team (NDST) and the National Advisory Committee on Drugs (NACD)
Annual report 2010: the state of the drugs problem in Europe.
1 First aid courses and use of Naloxone by drug users Experience gained with a model project by Fixpunkt e. V., Berlin Germany Prevention of emergencies.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
PERCODAN ABUSE *And Other Prescription Abuse* Kirsten Neilson Life, Society & Drugs Section 004.
DRUGS OF ABUSE Reynaldo J. Lesaca, M.D. Reynaldo J. Lesaca, M.D.
Trends and patterns in pharmaceutical use in Australia: What can we learn from those who have gone before us? Nicole Lee Roger Nicholas Ann Roche.
Drugs and Addiction. Specification – Page 48 1 Definition of the application biological bases social bases a) Define health psychology, showing understanding.
Forensic Science: Fundamentals & Investigations, Chapter 9 1 Chapter 9 Drug Identification and Toxicology By the end of this chapter you will be able to:
Learning Outcomes for Today
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Tom Waddell Urban Health Clinic: Patients Using Controlled Medicines* If you are taking controlled medicines, your safety is our highest priority! Our.
Psychoactive Drug Classifications.
Naloxone nasal spray in Norway Thomas Clausen Professor (Dr. med) 5. November 2015.
Drugged Driving Margaret Hague. New Epidemic Drinking and driving has been a major concern for a long time. Not only is texting and driving becoming a.
Brain Research Institute, UCLA Alison Taylor
The Role of Employers and Employee Assistance Programs in Addressing Opioid Use Disorders Teri L Leasure, LCSW, CCS EAP Coordinator Mid Coast Parkview.
Drugs and Toxicology Chapter 9. Drugs A substance (either natural or synthetic) that is used to produce effects (either physiological or psychological)
TEDI TEDI Trans European Drug Information Mireia Ventura – Energy control Barcelona Alexander Bücheli – City of Zurich youth counseling Streetwork.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
Addressing the issue: Prescription Drug Misuse in North Carolina
The challenge of new party drugs –
Magali Martinez, Agnès Cadet-Taïrou TREND UNIT, OFDT
ADDICTION AND UNHEALTHY LIFESTYLE
Fentanyl on Campus An overview of the VOICe Campus Health (and friends!) Approach to reducing risk at UBC Okanagan.
6% of adults had used one or more illicit drugs in last 12 months.
Medicinal and Recreational Drugs
MIREIA VENTURA VILAMALA, PhD
DR. Fernando Caudevilla Energy control (ABD)
PMMA (paramethoxymethamphetamine) in “legal highs” in Spain
Samantha Palmer Emery House Jillian Emerson
Drugs & The Dark Net Tim Bingham
Opiates and Opiods.
Opioid Crisis A Call to ACTION
‘New’ synthetic opioids in Europe: perspective from the EU EWS
Automating Profitable Growth™
By Braden Castro and Marissa Carpenter
Overdose Prevention and Management
New Psychoactive Substances (NPS) in Deep Web Marketplaces (DWM):
Results of an international drug testing service for cryptomarket users Mireia Ventura· ABD – Energy Control 15th May 2017.
The Global Marketplace
Mitigating the Safety Risks of Drugs With a Focus on Opioids: Are Risk Evaluation and Mitigation Strategies the Answer?  Marta J. Brooks, PharmD  Mayo.
Combatting the Opioid Epidemic
Trust and Culture on the Web
Causes of Drug Related Death
Point #1: Prices Matter 4.
The Use and Abuse of Drugs
Legalization of Drugs The Dutch experience.
Conducting Research in the “Real” World
The Global Marketplace
Naloxone in North Carolina
Cigarettes and Alcohol
Drugs and Addiction.
ADDICTION
Substance Use Prevention for Young Adults and Higher Education
Risk Reduction on New Drugs,
Teen vaping in Australia Does it increase smoking risk?
Presentation transcript:

Pol Quintana Mireia ventura The hidden web and the fentanyl problem: detection of ocfentanil as an adulterant in heroin Pol Quintana Mireia ventura

Credit Mireia Ventura Marc Grifell Alvaro Palma Liliana Galindo Iván Fornís Cristina Gil Xoán Carbón Fernando Caudevilla Magí Farré Marta Torrens

Background: the internet and drug supply Internet + non controlled substances = “Legal High/Research Chemical” phenomenon Internet + controlled substances = “Silk road” phenomenon

Background: the fentanyls Ocfentanil Patent 1959 1986 Medical use General anaesthesia, deep sedation, treatment of moderate to intense pain Clinical research stopped 1991 Never licenced as a drug. Active dose 50 µg (0,05mg) 30 µg (0,03mg) Legal status Scheduled Not scheduled

Background: the fentanyls problem Fentanyl use is a major concern in several contries such as USA, Canada, Australia, Estonia Fentanyl derivatives have been detected… In the surface web (butyrfentanil & 4-F-butyrfentanil, 2015) In the hidden web (acetylfentanyl & butyrfentanyl, 2016) Fentanyls have been used to adulterate heroin and other opiates for at least three decades, causing outbreaks of overdoses and deaths.

Why this talk? Case-study featuring an old problem (adulteration of heroin with fentanyl derivatives) in a new context (the hidden web) with a novel substance (ocfentanil)

“The effect is opiate of course, but not exactly like heroin” “For really addicted people there is a difference: the effect is shorter so they are sooner in withdrawal. One person said what alerted him was that when he took this heroin, he was in withdrawal every morning when he woke up.”

Methods

Methods

  Date Sold as Appearance Result Bought in/ sent from Additional features Sample #1 June 2015 Heroin White powder Ocfentanil, caffeine, paracetamol Hidden Web, 4/3/2015 Madrid Vendor: “FrenchConnection” Male, 36 years old Sample #2 October 2015 Not available Ocfentanil, caffeine (27%), paracetamol (33%), heroin (16%) Hidden Web, 5/9/2015 France Vendor: “Europdrugs” Sample #3 Ocfentanil, caffeine (26%), paracetamol (29%), heroin (3%) Sample #4 March 2016 Hidden Web, 10/3/2016 Vendor: Unknown Male, 45 years old

Other reports A British harm reduction organization, WEDINOS, also reported the combination of ocfentanil, paracetamol and caffeine in heroin samples bought from the hidden web. Chest pain, psychosis and agitation reported. One fatality due to heroin bought in the hidden web and adulterated with Ocfentanil.

Presence on the drug market Ocfentanil had never been detected in samples sold trough traditional markets. No web pages or individuals advertising ocfentanil were found on the surface internet or on any of the main hidden web marketplaces. The alert launched by Energy Control quickly spread in both the surface web and the hidden web. Discussion on fora pointed to two specific vendors (FRENCHCONNECTION and EuropeDrugs). Were eventually banned from marketplaces.

2013 4th sample sent to Energy Control (unknown vendor) March 2016 4th sample sent to Energy Control (unknown vendor) Sept 2013 Dutch police seizes batch of ocfentanil, caffeine and paracetamol March 2015 Belgium citizen found dead at home 2013 2013 2014 2015 2016 110 días Energy Control's 3 samples (Europdrugs & frenchconnection) 153 días Wedinos' 6 samples

Discussion We hypothesize that its introduction into the market was done by one unique agent, which did not consider selling the compound through the usual NPS and “legal highs” internet channels. Outbreaks of heroin adulterated with fentanyls might be very challenging if they originate from the internet. Drug testing might prove an useful monitoring tool, as new fentanyl derivatives will certainly emerge in the near future.

Conclusions The drug user community reacted to the adulteration. Although previous research has suggested that adulteration might be lower in hidden web marketplaces, it is indeed a real risk in the Deep Web.

A few questions for the audience… Is the extension of this phenomenon to the hidden web a sign that the fentanyls problem is growing? What was the drive that led to using ocfentanil as an adulterant, instead of other already marketed fentanyl derivatives such as butyrfentanyl or acetylfentanyl? As ocfentanil is not a world-wide controlled substance, why was it not sold as a “legal high” in the first place?

Thanks! Contact Mireia Ventura mireia@energycontrol.org Pol Quintana polquintana@gmail.com With the collaboration of: